Post autologous transplant (autoHCT)therapies in high risk MM. Subgroup analysis of Phase III BMTCTN 0702 STAMINA: autoHCT followed by lenalidomide maintenance(Len)(AM) vs auto HCT and Len and bortezomib (BZ) and dexamethasone consolidation Len maintenance(ACM) vs tandem autoHCT Len maintenance Meeting Abstract

  

Authors:	Krishnan, A.; Pasquini, M.; Blackwell, B.; Knust, K.; Bashey, A.; Devine, S.; Efebera, Y.; Ganguly, S.; Gasparetto, C.; Geller, N.; Giralt, S.; Parameswaran, H.; Horowitz, M.; Koreth, J.; Landau, H.; McCarthy, P.; McClune, B.; Nelson, C.; Qazilbash, M.; Shah, N.
Abstract Title:	Post autologous transplant (autoHCT)therapies in high risk MM. Subgroup analysis of Phase III BMTCTN 0702 STAMINA: autoHCT followed by lenalidomide maintenance(Len)(AM) vs auto HCT and Len and bortezomib (BZ) and dexamethasone consolidation Len maintenance(ACM) vs tandem autoHCT Len maintenance
Meeting Title:	16th International Myeloma Workshop
Journal Title:	Clinical Lymphoma, Myeloma and Leukemia
Volume:	17
Issue:	1 Suppl.
Meeting Dates:	2017 Mar 1-4
Meeting Location:	New Delhi, India
ISSN:	2152-2650
Publisher:	Elsevier Inc.
Date Published:	2017-02-01
Start Page:	e5
Language:	English
ACCESSION:	122646535
DOI:	10.1016/j.clml.2017.03.009
PROVIDER:	EBSCOhost
PROVIDER:	cin20
DOI/URL:	http://search.ebscohost.com/login.aspx?direct=true&db=cin20&AN=122646535&site=ehost-live
Notes:	Meeting Abstract: OP-008 -- Source: cin20

https://synapse.mskcc.org/synapse/works/has_related_data_chk/109861